Who is sponsoring TORTUGA?

TORTUGA is sponsored by Galapagos NV.

What condition does TORTUGA study?

TORTUGA studies Ankylosing Spondylitis.

What drugs are being tested in TORTUGA?

Interventions: filgotinib, Placebo Oral Tablet.

What is the status of TORTUGA?

TORTUGA is currently COMPLETED.

Last reviewed 2018-08-13 · How we verify

A Study to Assess Efficacy and Safety of Filgotinib in Ankylosing Spondylitis (TORTUGA)

NCT03117270 PHASE2 COMPLETED

This is a multicenter, Phase 2, double-blind, placebo-controlled study in subjects with active Ankylosing Spondylitis (AS). A total of approximately 100 subjects will be randomized to one of 2 treatment arms in a 1:1 ratio: oral filgotinib tablets q.d. or matching placebo q.d. Treatment duration will be 12 weeks. Each subject will stay in the study for a maximum of 20 weeks (from Screening visit to Follow-up visit).

Details

Lead sponsor	Galapagos NV
Phase	PHASE2
Status	COMPLETED
Enrolment	116
Start date	Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Jul 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Ankylosing Spondylitis

Interventions

filgotinib
Placebo Oral Tablet

Countries

Ukraine, Belgium, Estonia, Poland, Bulgaria, Spain, Czechia